Suzanne Kamel-Reid
Affiliations: | University of Toronto, Toronto, ON, Canada |
Area:
Molecular BiologyGoogle:
"Suzanne Kamel-Reid"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Reis PP, Tokar T, Goswami RS, et al. (2020) A 4-gene signature from histologically normal surgical margins predicts local recurrence in patients with oral carcinoma: clinical validation. Scientific Reports. 10: 1713 |
| Dhani NC, Hirte HW, Wang L, et al. (2020) Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Nikbakht H, Jessa S, Sukhai MA, et al. (2020) Latency and interval therapy affect the evolution in metastatic colorectal cancer. Scientific Reports. 10: 581 |
| Puckrin R, Atenafu EG, Claudio JO, et al. (2020) Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia. Haematologica |
| Malone ER, Saleh RR, Yu C, et al. (2019) OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing. Current Oncology (Toronto, Ont.). 26: e618-e623 |
| Murphy T, Zou J, Daher-Reyes GS, et al. (2019) Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML. Blood Advances. 3: 2307-2311 |
| Moncur JT, Bartley AN, Bridge JA, et al. (2019) Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Archives of Pathology & Laboratory Medicine |
| Rodriguez-Freixinos V, Lheureux S, Mandilaras V, et al. (2019) Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients. Gynecologic Oncology |
| Perdrizet K, Stockley T, Law JH, et al. (2019) Non-small cell lung cancer (NSCLC) next generation sequencing (NGS) using the Oncomine Comprehensive Assay (OCA) v3: Integrating expanded genomic sequencing into the Canadian publicly funded health care model. Journal of Clinical Oncology. 37: 2620-2620 |
| Campbell PA, Thavorn K, Lo B, et al. (2019) Abstract 3355: Challenges in the implementation of molecular diagnostic testing for non-small cell lung cancer Cancer Research |